Speaking with heartwire, the lead investigator on the new analysis, Dr Alok Gupta (Pennington Biomedical Research Center, Baton Rouge, LA), said that he hopes the drug is approved given the epidemic of obesity and hypertension. See all stories on this topic »
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment